Monday, June 30, 2014

10 Best Medical Stocks For 2014

Here are today's top news headlines from�Fool.com. Check back throughout the day as this list is updated, and follow us on Twitter at�TMFBreaking.

DISH Counters SoftBank CEO's Attack

New York Times Reports Circulation Gains

Costco Increases Dividend

Year-Over-Year Home Price Gains at 2006 Levels

Pentagon Closes Out April With $2.8 Billion in Contracts

Oil Sinks on China Manufacturing and U.S. Supplies

Booz Allen to Share $65.6 Million Navy Contract

Corinthian Colleges Appoints Leon Panetta to Its Board

Lockheed Selling 18 F-16 Fighter Jets to Iraq

PepsiCo Pulls Mountain Dew Ad After Criticism

Yahoo! Launches Android App

PepsiCo Raises Dividend for 41st Consecutive Year

Around the World, Angry Workers Unite on May Day

Haemonetics Completes Hemerus Medical Acquisition

ECB Weighs Rate Cut as Eurozone Economy Struggles

Duke Joint Venture Takes Stake in Calif. Power Transmission Line

Best Healthcare Equipment Stocks To Buy For 2015: Alere Inc (ALR)

Alere Inc., incorporated on May 11, 2001, is a provider of point-of-care diagnostics and services. The Company's products and services help healthcare practitioners make treatment decisions and improve outcomes for individuals living with chronic disease. The Company's portfolio also includes a range of health information solutions that access to critical health data, provide clinical decision support, and facilitate performance reporting and analysis. The Company�� segment includes professional diagnostics, health information solutions and consumer diagnostics. The Company distributes its professional diagnostic products to hospitals, reference laboratories, physician offices and other point-of-care settings through an worldwide distribution networks. In February 2013, the Company acquired Epocal, Inc.

Professional Diagnostics

Professional diagnostics are generally designed to assist medical professionals in both preventative and interventional medicine, and include testing and monitoring performed in hospitals, laboratories and doctors' offices and, increasingly, patient self-testing, which the Company defines as testing or monitoring performed at home under the supervision of a medical professional. Professional diagnostic products provide for qualitative or quantitative analysis of patient samples for evidence of a specific medical condition, disease state or toxicological state or to measure response to therapy. The point-of-care market for rapid diagnostic products includes all areas where a patient is assessed or diagnosed, including hospitals, laboratories, physician offices, specialized mobile clinics, emergency rooms, rapid-response laboratories and patient health screening locations.

The Company's Alere Cholestech LDX System is a point-of-care monitor of blood cholesterol and related lipids which is used to test patients at risk of, or suffering from, heart disease and related conditions. The Alere Cholestech LDX System makes it possible to provide ! a complete lipid profile with tests for total cholesterol, high-density lipoprotein cholesterol (HDL) and low-density lipoprotein cholesterol (LDL), triglycerides, and glucose. The Company's Alere INRatio System is an easy-to-use, hand-held blood coagulation monitoring system for use by patients and healthcare professionals in the management of warfarin, a commonly prescribed medication used to prevent blood clots. The Company also offers the epoc Blood Analysis System for bloods gas, electrolyte and metabolite testing, which is manufactured by its recently acquired Epocal division. The epoc (enterprise point-of-care) platform is a point-of-care analysis system which provides Wireless bedside blood gas, electrolyte and metabolite measurement testing solutions and complements the Company's Alere Triage products in cardiology and emergency room settings.

The Company develops and markets a range of point-of-care tests for influenza A/B, RSV, strep throat, pneumonia, C. difficile, infectious mononucleosis, HIV, herpes simplex virus (HSV-2), hepatitis C (HCV), hepatitis B (HBV), malaria, lyme disease, Chlamydia, H. pylori, rubella and other infectious diseases. The Company's tests for infectious disease are sold under brand names that include Alere, Alere Determine, Acceava, BinaxNOW, Clearview, DoubleCheckGold, Panbio, SD, TECHLAB and Alere TestPack. In addition to point-of-care products, the Company also offers a line of indirect fluorescent antibody, or IFA, assays for over 20 viral, bacterial and autoimmune diseases, a full line of serology diagnostic products covering a range of disease categories and over 50 enzyme-linked immunosorbent assay (ELISA), tests for a range of infectious and autoimmune diseases, as well as a full line of automated instrumentation for processing ELISA tests.

The Company offers laboratory-based testing services throughout Europe under the name Alere Toxicology, formerly Concateno, and in the United States under the names Alere Toxicology Services, or! Alere To! xicology, and Redwood Toxicology Laboratory, or Redwood. The Company offers point-of-care diabetes products, including its Afinion Analyzer System and its NycoCard System. The Company's Alere Connect products include HealthPAL and HealthCOM.

Health Information Solutions

The Company's health information solutions are designed to provide physicians with actionable data that allows them to make more decisions in real time, deliver quality care, and put the individuals they treat on a pathway to better health. The Company offers a range of software-based analytics, clinical decision support tools, and accountable cares programs that enable healthcare providers to initiate earlier interventions, personalize treatment plans, lower costs by reducing hospital readmissions, and measure improvements in outcomes at both a patient and population level. With this range of scalable solutions, the Company is able to support healthcare practitioners in the transition to accountable care, as well as in meeting the new pay-for-performance guidelines set by the Centers for Medicare & Medicaid Services (CMS).

The Company's Women's and Children's Health division delivers a range of obstetrical care services that range from risk assessments focused on identifying women who may experience pregnancy complications to a neonatal program that supports early infant care management. The Company offers home-based obstetrical monitoring for pregnant women with medical or pregnancy-related problems that could puts their health or the health of their babies at risk. The Company also delivers telephonic and home-based nursing services that support improved clinical outcomes. The Company offers a suite of integrated wellness programs and resources that is designed to reduce participant health risks and healthcare-related costs. The Company's wellness programs include screening for risk factors associated with chronic disease, particularly tobacco use, poor nutrition, physical inactivity, and chron! ic stress! .

The Company offers services designed to support anticoagulation management for patients who takes warfarin to control their risk for stroke and clotting disorders. Alere Home Monitoring, the Company's patient self-testing business, assists patients in acquiring home INR monitors and with insurance coverage determinations and provides physicians with a comprehensive model that allows them to incorporate patient self-testing into their practices.

Consumer Diagnostics

The Company's consumer diagnostic products consist of the Company's First Check brand of over-the-counter drug tests for at-home testing for up to seven illicit drugs and five prescription drugs, as well as First Check brand over-the-counter tests for cholesterol monitoring. The Company also sells Balance Activ Vaginal Gel directly to consumers and healthcare professionals for the treatment of bacterial vaginosis without antibiotics.

The Company competes with Abbott, Siemens, Beckman Coulter, Johnson & Johnson, Roche, Abaxis Medical Diagnostics, International Technidyne Corporation, INOVA Diagnostics, DiaSorin, Diamedx and Qiagen.

Advisors' Opinion:
  • [By Seth Jayson]

    Calling all cash flows
    When you are trying to buy the market's best stocks, it's worth checking up on your companies' free cash flow once a quarter or so, to see whether it bears any relationship to the net income in the headlines. That's what we do with this series. Today, we're checking in on Alere (NYSE: ALR  ) , whose recent revenue and earnings are plotted below.

10 Best Medical Stocks For 2014: InVivo Therapeutics Holdings Corp (NVIV)

InVivo Therapeutics Holdings Corp., formerly Design Source, Inc., incorporated on April 2, 2003, is a development-stage company. The Company is developing and commercializing technologies for the treatment of spinal cord injuries. The Company develops biopolymer scaffolding devices for the treatment of spinal cord injuries. The biopolymer devices are designed to protect the damaged spinal cord from further secondary injury and promote neuroplasticity, a process where functional recovery can occur through the rerouting of signalling pathways to the spared healthy tissue.

The Company�� biopolymer-based devices are surgically implanted or injected into the lesion created during traumatic injury, or the primary injury. Additional applications of its platform technologies include the treatment for, spinal cord injury following tumor removal, peripheral nerve damage, and postsurgical treatment of any transected nerve. Its biocompatible scaffolding device for the treatment of acute spinal cord injury, is regulated as a Class III medical device by the Food and Drug Administration (FDA). The Company's biocompatible hydrogel is used for the local release of methylprednisolone to treat acute spinal cord injuries and the biocompatible polymer scaffolding device seeded with autologous human neural stem cells.

The Company�� porous biopolymer scaffold consists of polylactic-co-glycolic acid (PLGA) and-polylysine. PLGA is a biodegradable and biocompatible polymer, which is used for applications, such as surgical sutures (Dolphin sutures and Ethicon sutures), drug delivery (Lupron Depot and Sandostatin LAR Depot), and tissue engineering (Dermagraft). The PLGA-polylysine biopolymer scaffolding device is biocompatible and biodegradable and degrades naturally inside the body without requiring subsequent removal.

The Company focuses to develop an injectable hydrogel designed to counteract the inflammatory environment that results during a secondary injury from a closed-wound spi! nal cord injury where further cell death occurs. It focuses to counteract the pathophysiology of spinal cord injury by replacing lost cells of the spinal cord and activating endogenous regenerative processes, such as the formation of new synapses and axonal sprouting based on molecules the stem cells produce.

Advisors' Opinion:
  • [By Bryan Murphy]

    I came close to pointing this out yesterday, but didn't pull the trigger. Though delaying didn't cost you or me more than a few cents, I don't want to tarry any longer... Invivo Therapeutics Holdings Corp. (OTCBB:NVIV) is a buy.

10 Best Medical Stocks For 2014: ZELTIQ Aesthetics Inc (ZLTQ)

ZELTIQ Aesthetics, Inc. (ZELTIQ), incorporated on March 22, 2005, is a medical technology company. The Company is focused on developing and commercializing products utilizing its controlled-cooling technology platform. Its commercial product is the CoolSculpting System that reduces stubborn fat bulges. The Company generates revenues from capital sales of its CoolSculpting System and from procedure fees its physician customers pay for each CoolSculpting procedure they perform. As of March 31, 2011, it had an installed base of 346 and 475 CoolSculpting Systems worldwide and over 88,000 CoolSculpting procedures had been sold to its physician customers. The Company markets CoolSculpting to the dermatologists, plastic surgeons, and aesthetic specialists. As of March 31, 2011, ZELTIQ�� North American direct sales force consisted of 23 professionals, and over 88,000 CoolSculpting procedures were sold to ZELTIQ�� physician customers.

CoolSculpting System

ZELTIQ generates revenues from capital sales of its CoolSculpting System and from procedure fees its physician customers pay for each CoolSculpting procedure they perform. Capital sales of ZELTIQ�� CoolSculpting System include the CoolSculpting control unit and its CoolSculpting vacuum applicators. ZELTIQ generates procedure fees through sales of CoolSculpting procedure packs, which include its consumable gelpads and liners and a disposable computer cartridge that it markets as the CoolCard. The CoolCard contains enabling software that permits its physician customer to perform a fixed number of CoolSculpting procedures.

The CoolSculpting control unit is the base of the CoolSculpting System. ZELTIQ�� CoolSculpting control unit also contains software that tracks and collects data about each procedure performed and any error messages that may be generated during the procedure. CoolSculpting System includes three CoolSculpting vacuum applicators. ZELTIQ�� CoolSculpting procedure packs facilitate the pay-per-procedu! re feature of its CoolSculpting System. Its CoolSculpting procedure packs include CoolCard and its consumable gelpads and liners.

Advisors' Opinion:
  • [By Sean Williams]

    Zeltiq Aesthetics (NASDAQ: ZLTQ  )
    Last, but certainly not least, we have Zeltiq Aesthetics, which utilizes its proprietary medical devices for the selective reduction of fat in patients. Understandably, we're not talking about a pharmacological solution here or even a long-term one necessarily. This is more of an aesthetic solution in cases where diet and exercise aren't meeting the patients' goal, but it should be noted that people will pay top dollar to look healthier and thinner, so Zeltiq's target audience is actually very large.

  • [By John Udovich]

    On Tuesday, small cap biotech stock Kythera Biopharmaceuticals Inc (NASDAQ: KYTH) surged around 25% after announcing that its ATX-101 REFINE-1 and REFINE-2 Phase III trials met all primary and secondary endpoints for the reduction of so-called double chins; but if investors missed out on that rally, small caps Zeltiq Aesthetics Inc (NASDAQ: ZLTQ), Solta Medical Inc (NASDAQ: SLTM) and Cynosure, Inc (NASDAQ: CYNO) each have a piece of the aesthetic market as well. In the case of Kythera Biopharmaceuticals, its ATX-101 can be injected to deal with double chins���meaning its less invasive than liposuction as the drug dissolves fat cells but leaves other tissue alone. JP Morgan has noted:

10 Best Medical Stocks For 2014: Cyberonics Inc (CYBX)

Cyberonics, Inc. (Cyberonics), incorporated in 1987, is a medical device company. The Company is engaged in the design, development, sales and marketing of implantable medical devices that provide a neuromodulation therapy, vagus nerve stimulation therapy (VNS Therapy), for the treatment of refractory epilepsy and treatment-resistant depression (TRD) and other device solutions for the management of epilepsy.VNS Therapy System includes an implantable pulse generator to provide stimulation to the vagus nerve; a lead that connects the generator to the vagus nerve; equipment to assist with implantation surgery; equipment to assist with setting the stimulation parameters for each patient; instruction manuals, and magnets to suspend or induce stimulation manually. The VNS Therapy pulse generator and lead are surgically implanted into patients generally during an outpatient procedure. The VNS Therapy System consists of a pulse generator, a bipolar lead, a programming wand and software and a tunneling tool.

The United States Food and Drug Administration (FDA) approved the Company's VNS Therapy System in July 1997 for use as an adjunctive therapy in epilepsy patients over 12 years of age for reducing the frequency of partial onset seizures that are refractory or resistant to antiepileptic drugs. Regulatory bodies in Canada, the European Economic Area, certain countries in Eastern Europe, Russia, South America, Africa, Australia and certain countries in Asia, including Japan, China and Taiwan, have approved the VNS Therapy System for the treatment of epilepsy, many without age restrictions or seizure-type limitations. In July 2005, the FDA approved the Company's VNS Therapy System for the adjunctive long-term treatment of chronic or recurrent depression for patients 18 years of age or older who are experiencing a depressive episode and have not had an adequate response to four or more adequate anti-depressant treatments. Regulatory bodies in the European Economic Area, Canada and Israel have approv! ed the Company's VNS Therapy System for the treatment of chronic or recurrent depression in patients who are in a treatment-resistant or treatment-intolerant depressive episode without age restrictions.

In February 2011, the Company announced FDA approval of its fifth generation generator, the AspireHC generator. In August 2011, the Company announced that the Company discovered a hardware-related design issue with the AspireHC Model 105 and AspireSR (Seizure Response) Model 106 generators. In December 2011, the FDA approved the Company's re-designed AspireHC generator, and the Company resumed its limited commercial release of the generator in the United States.

Pulse Generator

The pulse generator is an implantable, programmable signal generator designed to be coupled with the bipolar lead to deliver mild electrical pulses to the vagus nerve. The pulse generator is a battery-powered device. Before or upon depletion of the battery, the pulse generator may be removed and a new generator implanted in a short, outpatient procedure. The Model 102 (Pulse), Model 102R (Pulse Duo ), Model 103 (Demipulse), Model 104 (Demipulse Duo) and Model 105 (AspireHC), are the VNS Therapy pulse generators the Company offers and are similar in design and manufactures to a cardiac pacemaker.

Bipolar Lead

The bipolar lead conducts the electrical signal from the pulse generator to the vagus nerve. The lead incorporates electrodes, which are self-sizing, minimizing mechanical trauma to the nerve. The lead's two electrodes and anchor tether wrap around the vagus nerve, and the connector end is tunneled subcutaneously to the upper chest area, where it attaches to the pulse generator. The Company offers three lead models in the United States. The leads are available in two inner spiral diameter sizes to ensure optimal electrode placement on different-sized nerves.

Programming Wand and Software

The Company's programming wand and software are us! ed to int! errogate the implanted pulse generator and to transmit programming information from a handheld computer to the pulse generator via an inductive coupling. Programming capabilities include modification of the pulse generator's programmable parameters (pulse width, amplitude and frequency and stimulation ON and OFF intervals) and storage and retrieval of telemetry data.

Tunneling Tool

The tunneling tool is a single use, sterile, disposable surgical tool designed to be used during surgical placement of the bipolar lead. The tool is used for subcutaneous tunneling of the lead between the nerve site in the neck and the pulse generator site in the upper chest area.

Accessory Pack

The accessory pack includes two resistor assemblies used to test the function of the device prior to implantation, the bipolar lead tie-downs and one hex screwdriver. The patient kit includes two magnets, one watch-style and one pager-style.

The Company competes with Medtronic, Inc., NeuroSigma Inc. and CerboMed GmbH.

Advisors' Opinion:
  • [By Seth Jayson]

    Calling all cash flows
    When you are trying to buy the market's best stocks, it's worth checking up on your companies' free cash flow once a quarter or so, to see whether it bears any relationship to the net income in the headlines. That's what we do with this series. Today, we're checking in on Cyberonics (Nasdaq: CYBX  ) , whose recent revenue and earnings are plotted below.

  • [By James E. Brumley]

    Investors who were hoping things would work out for epilepsy treatment company Cyberonics, Inc. (NASDAQ:CYBX) can cross CYBX off their list of epilepsy-oriented stocks to buy, as they did with Acorda Therapeutics Inc. (NASDAQ:ACOR) about a month ago. ACOR saw its epilepsy drug Plumiaz rejected by the FDA in early May, while CYBX announced this morning that the coming fiscal year's (beginning in April) revenue would be weaker than first expected as sales of its epileptic control implant device didn't look quite as promising as hoped.

10 Best Medical Stocks For 2014: Cytomedix Inc (CMXI)

Cytomedix, Inc. (Cytomedix), incorporated in April 29, 1998, is a regenerative therapies company marketing and developing products within the United States and internationally .The Company commercializes cell-based technologies that harness the regenerative capacity of the human body to trigger natural healing. The Company is a commercial operation, and a robust clinical pipeline representing a logical extension of its commercial technologies in the evolving field of regenerative medicine. Cytomedix primarily operates in the United States. Its commercial offerings are centered on its point of care platform technologies for the safe and efficient separation of blood and bone marrow to produce platelet based therapies or cell concentrates.

The Company markets and selsl two distinct platelet rich plasma (PRP) technologies, the AutoloGel System for wound care and the Angel concentrated Platelet Rich Plasma (cPRP) Sytem in orthopedic and cardiovascular markets. Its clinical pipeline includes the ALDH, which are cell-based therapies (Bright Cells). In February 2012, the Company acquired Aldagen, Inc.

The AutoloGel System

The AutoloGel System is a point of care device for the production of a platelet based bioactive therapy derived from a small sample of the patient�� own blood. Using the patient�� own platelets as a therapeutic agent, AutoloGel harnesses the body�� natural healing processes to deliver growth factors, chemokines and cytokines known to promote angiogenesis and to regulate cell growth and the formation of new tissue.

Angel Product Line

The Angel concentrated Platelet Rich Plasma (cPRP) System is a multi-functional cell separation device which produces concentrated platelet rich plasma for use in the operating room and clinic and is used in a range of orthopedic and cardiovascular indications. Similar to the AutoloGel System, the Angel System is a point of care device for the production of a concentrated, aseptic platelet! -based bioactive therapy derived from a small sample of the patient�� own blood. The resulting cPRP is applied at the site of injury to promote healing. The Angel product line also includes ancillary products such as phlebotomy and applicator supplies and activAT. activAT is designed to produce autologous thrombin serum from platelet poor plasma and is sold exclusively in Europe and Canada, where it provides a safe alternative to bovine-derived products.

ALDHbr Cell Technology and Development Pipeline

The ALDHbr (Bright Cell) technology is an approach to cell-based regenerative medicine and a logical extension of its commercial technologies in the evolving regenerative medicine market, with potential clinical indications in markets with unmet medical needs such as peripheral arterial disease and ischemic stroke. The Bright Cell technology is in that it utilizes an intracellular enzyme marker to facilitate fractionation of essential regenerative cells from a patient�� bone marrow. The bone marrow fractionation process identifies and isolates active stem and progenitor cells expressing high levels of the enzyme aldehyde dehydrogenase, or ALDH, which is a key enzyme involved in the regulation of gene activities associated with cell proliferation and differentiation.

The Company�� lead product candidate, ALD-401, is an autologous preparation of Bright Cells for the post-acute treatment of ischemic stroke. ALD-401 is being evaluated in the RECOVER-Stroke clinical study, an ongoing 100-patient, double-blind, placebo-controlled Phase 2 study in patients with unilateral, cerebral ischemic stroke with an NIH stroke scale score of less than 22. An additional product candidate, ALD-301, is in clinical development for peripheral arterial disease (PAD), a condition causing reduced flow of blood and oxygen to muscles in the leg. It has completed a Phase 1/2 study of autologous ALD-301 in critical limb ischemia (CLI), a late stage condition caused by PAD. The Phase 2 PACE! (Patient! s with Intermittent Claudication Injected with ALDH Bright Cells) study is an 80 patient, double-blind, placebo-controlled clinical trial intended to demonstrate the safety and efficacy of ALD-301 (Bright Cells) in patients diagnosed with IC.

The Company competes with Harvest Technologies (a subsidiary of Terumo), Biomet, Arteriocyte, and Arthrex.

Advisors' Opinion:
  • [By James E. Brumley]

    To give credit where it's due, Cytomedix, Inc. (OTCBB:CMXI) and Baxter International Inc. (NYSE:BAX) have both helped shape the landscape of the hemostasis (bleeding control) market with their products, AutoloGel and TISSELL, respectively. Arch Therapeutics Inc. (OTCBB:ARTH) has proverbially taken their concepts "up a notch", however, and its direct solution to a problem that CMXI and BAX can't quite solve may make ARTH the hottest trading candidate in the hemostasis space.

  • [By Bryan Murphy]

    When traders think of post-surgical wound management stocks, they may first think of names like Cytomedix, Inc. (OTCBB:CMXI) or Alliqua Inc. (OTCMKTS:ALQA). And well they should. Both companies have something of a history in the arena. ALQA is the purveyor of SilverSeal and Hydress antibiotic bandages, while CMXI is the developer of the AutoloGel system, which induces an affected patient's on body to do what it's supposed to do if there's a wound that won't heal. Cytomedix also makes the Angel platelet-rich plasma (PRP) delivery system. There's a relatively new name to add to the list of game-changing stocks in wound-management industry, however.... Arch Therapeutics Inc. (OTCBB:ARTH). The company is developing - well, has developed - a product called AC5 that nips post-surgical bleeding in the bud, largely negating the need for other post-surgical bleeding-control measures.

10 Best Medical Stocks For 2014: Opt-Sciences Corp (OPST)

Opt-Sciences Corporation, incorporated on November 1956, conducts its business through its wholly owned subsidiary, O and S Research, Inc. The Company deposits anti-glare and/or transparent conductive optical coatings on glass used primarily to cover instrument panels in aircraft cockpits. It also provides full glass cutting, grinding and painting operations, which augment its optical coating capabilities. Its products are designed to enable pilots to read aircraft instruments in direct sunlight or at night or in covert situations using appropriate night vision filters or to protect the instruments from electromagnetic interference. The Company�� business is dependent on a robust commercial, business, and regional aircraft market and to a lesser degree the military aircraft market. It generally has a four to twelve week delivery cycle depending on product complexity, available plant capacity and required lead time for specialty raw materials, such as polarizers or filter glass.

The Company�� offers incorporate an optical coating of some type. Its primary coatings are for aircraft cockpit display applications and consist of its anti-reflection coating used for glare reduction and its transparent conductive coating used for electromagnetic interference shielding. In addition, it also offers a full range of other specialty instrument glass, including night vision filter glass, circular polarizers, touchpads, glass sandwiches for liquid crystal displays (LCDs) as well as other custom designed specialty glass components and assemblies. It uses its technology to apply a micro thin optical non-glare and/or conductive coating to the glass. Both processes utilize the deposit of a thin film of metal or metal oxide on the surface of the glass. The process takes place in a heated vacuum chamber. It heats the deposited material to over 1800 degrees Centigrade causing it to evaporate.

The Company competes with JDSU, Mod A Can, Dontech, Schott Glass and Hoya Optics

Advisors' Opinion:
  • [By Geoff Gannon] ng>Micropac

    Micropac is 76% owned by Heinz-Werner Hempel. He�� a German businessman. You can see the German company he founded here. He�� had control of Micropac for a long-time. I don�� have an exact number in front of me. But I would guess it�� been something like 25 years.

    ADDvantage

    ADDvantage Technologies is controlled by the Chymiak brothers. See the company�� April 4 press release explaining their decision to turn over the CEO position to an outsider. Regardless, the Chymiaks still control 47% of the company. Ken Chymiak is now chairman. And David Chymiak is still a director and now the company�� chief technology officer. Clearly, it�� still their company.

    By the way, the name ADDvantage Technologies has nothing to do with the Chymiaks. Today�� AEY really traces its roots to a private company called Tulsat. The Chymiak brothers acquired that company about 27 years ago. So, effectively, when you buy shares of AEY you are buying into a 27-year-old family-controlled company.

    That�� pretty typical in the world of net-nets.

    Solitron

    Solitron Devices is 29% owned by Shevach Saraf. He has been the CEO for 20 years. The post-bankruptcy Solitron has never known another CEO. Before the bankruptcy, Solitron was a much bigger, much different company. So even though we are not talking about the founder here ��and even though 70% of the company�� shares are not held by the CEO ��we��e still talking about a company where one person has a lot of control. Solitron only has three directors. Saraf is the chairman, CEO, president, CFO and treasurer. Neither of the other two directors joined the board within the last 15 years. So, we aren�� talking about a lot of tumult at the top.

    In fact, profitable net-nets seem to be especially common candidates for abandoning the responsibilities of a public company without actually getting taken private.

    OPT-Sciences

    This company is controlled by Arthu

10 Best Medical Stocks For 2014: Marcolin SpA (MCL)

Marcolin SpA is an Italy-based eyewear manufacturer. It is a manufacturer of glasses and sunglasses for such brands as Tom Ford, Roberto Cavalli and Just Cavalli, Diesel, Montblanc, Tod's and Hogan, Balenciaga, Swarovski, Timberland, DSquared2 and Kenneth Cole. Advisors' Opinion:
  • [By John McCamant]

    Our top stock selection for 2014 has received three Breakthrough Therapy Designations (BTD) by the FDA, and subsequent approval, in November, for Imbruvica, a very safe pill that has shown unprecedented efficacy to treat mantle cell lymphoma (MCL), suggests John McCamant, editor of The Medical Technology Stock Letter.

Sunday, June 29, 2014

Top 10 Telecom Stocks To Watch Right Now

Top 10 Telecom Stocks To Watch Right Now: Internet Gold Golden Lines Ltd (IGG)

Internet Gold Golden Lines Ltd., incorporated in April 1992, is a communications services provider. The Companys subsidiaries are B Communications Ltd. (B Communications) (formerly 012 Smile.Communications Ltd.) and GoldMind Ltd. (formerly Smile.Media Ltd.). B Communications is the controlling shareholder of Bezeq. It owns 78.11% of the interest B Communications. Bezeq is the principal provider of communications services in Israel. The Group has four areas of operation, which include Bezeq domestic fixed-line communications, Pelephone Communications Ltd., Bezeq International Ltd. and D.B.S. Satellite Services (1998) Ltd. The Companys subsidiary, B Communications, holds 30.44% interest of Bezeq (TASE:BZEQ). On March 14, 2011, B Communications purchased additional interest in Bezeq increasing its ownership interest to 31.37%. On March 3, 2011, Partner completed its acquisition of 012 Smile.

Bezeq domestic fixed-line communications primarily includes Bezeq s operation as a domestic operator, including telephony services, Internet services, transmission services and data communications. Pelephone Communications Ltd. provides cellular services (cellular communications), marketing of end-user equipment, installation, operation and maintenance of cellular communications equipment and systems. Bezeq International Ltd. provides international communications services, Internet access (ISP) services, and network endpoint (NEP) services. D.B.S. Satellite Services (1998) Ltd. provides multi-channel broadcast and value added services via satellite.

Bezeq fixed-line business

Bezeq's telephony services include basic telephony services on domestic telephone lines and associated services, such as voice mail, caller identity (ID), call waiting, call forwarding, speed dial, and conference calls. Bezeq also provides national services for businesses (1-800, 1-700) that offer full or partial paymen! t for incoming calls b y businesses. As of December 31, 2010, Bezeq operated about ! 12,500 public telephones around the country, which were operated by various types of pre-paid cards. Bezeq operates a unified telephone directory for fixed-line and cellular telephony operators, as well as a unified Website, which is free of charge, in addition to its 144 (directory information) service. As of December 31, 2011, Bezeq had 2,367,000 active telephone lines.

Bezeq provides broadband Internet access infrastructure services in xDSL technology. As of December 31, 2011, Bezeq had 1,111,000 Internet subscribers. Data communications services are network services for point-to-point transfer of data, transfer of data between computers and various communications networks, services to connect communications networks to the Internet, and remote access services. The companies operating in this field are Cellcom, Partner (which acquired the Med-1 operation), HOT and Internet companies that also use leased infrastructures. Bezeq offers transmission services, in cluding high speed services, to other communications operators and to its business customers over a variety of protocols. At December 31, 2011, the percentage of Internet subscribers connected to the next generation network (NGN) was approximately 87% of Bezeq's total Internet subscribers, and the percentage of subscribers using NGN services was 48% of all Internet subscribers connected to the NGN network.

Bezeq provides services to other communications operators, including the cellular and international operators, cable broadcasting license-holders, NEP operators, ISPs, domestic operators, and Palestinian communications providers. Bezeqs services include infrastructure, connection to Bezeq's network, transmission, billing and collection, rental of space and provision of services in its rented properties and rights of use for seabed cables. Bezeq operates and maintains radio transmitters, including those operated by the Israel Broadc! asting Au! thority, televisi on transmitters of Channel 1, Educational Television and Cha! nnel 2, a! nd the transmitters of regional radio stations. Bezeq also operates digital terrestrial television (DTT) transmitters. Bezeq is responsible only for operation and maintenance of the transmitters for distribution of radio and television programs, and not for the content of the broadcasts.

Bezeq performs setup and operation work on networks and sub-networks for various customers, such as the Ministry of Defense, HOT, radio and television broadcasting companies, cellular and international communication operators, local authorities, municipalities and government agencies. Bezeq and HOT have agreements for the provision of installation and maintenance services of cable networks, on Bezeq's infrastructure, from the starting point of those licensees operating center, up to the point of delivery at the entrance to subscribers homes. The IP Centrex service is a virtual private exchange service. Data Center service enables provision of a solution for customers from the aspects of backup and survivability. 144 Internet site is a search engine for finding business and private telephone numbers. Bezeqs launch of its new generation network (NGN) has enabled it to offer new services, such as Bphone (a service enabling telephone calls to be made through the Internet as calls made from a fixed-line phone), on-hold music, storage services on the network and home exchange services.

Pelephone

Pelephone provides its subscribers with an offering of voice transmission, transmission of text messages, data communications and advanced multimedia services. Pelephones service package includes basic call services, call completion services and auxiliary services, such as call waiting, call forwarding, voice mail, voice conference call and caller ID. Pelephone offers its customers value added services, such as Internet surfing, text messaging and information services using short message service SMS (t! ext), mul! timedia messagi ng service (MMS) messages, voice information services using ! special p! urpose asterisks, information and entertainment services through as Internet portal. Pelephones value added services also include the ability to watch various television channels, such as music, sports, news and entertainment channels, and the ability to photograph and forward video files.

Pelephone provides roaming services (communications by means of cellular handsets from different locations around the world) in accordance with agreements it has with cellular operators abroad, enabling Pelephone to access their networks. Pelephone offers its customers a repair service for a monthly payment entitling the customer to a warranty for the cellular handset, or for a one-time payment at the time of repair. Pelephone offers its customers various types and brands of cellular telephones, on-board telephones and hands-free devices, as well as support for its range of services. Pelephone also supplies its customers with modems and laptop computers for surfing the Int ernet through the Pelephone network. Pelephone provides roaming services (communications by means of cellular handsets from different locations around the world) in accordance with agreements it has with cellular operators abroad, enabling Pelephone to access their networks. The roaming tariffs are defined in the Individual Annex. Pelephone offers its customers a repair service for a monthly payment entitling the customer to a warranty for the cellular handset, or for a one-time payment at the time of repair. Pelephone offers its customers various types and brands of cellular telephones, on-board telephones and hands-free devices, as well as support for its range of services. Pelephone also supplies its customers with modems and laptop computers for surfing the Internet through the Pelephone network.

Bezeq International

Bezeq International provides communication solutions to its customers in the private and business se! ctors, in! four areas of operati on. It includes Internet access services, International tele! phony ser! vices, NEP services, and Data and Information and Communication Technology (ICT), solutions. In the voice services sector, Bezeq International provides international direct dialing (IDD), services to business and private customers; toll-free number services for business customers overseas; international call routing and termination services (hubbing) transfer of international calls between foreign communication providers (worldwide), calling card services enabling prepaid and postpaid dialing from and to Israel, for business and private customers, and the 1809 service for dialing from Israel to other countries. Bezeq International also provides domestic telephony services by means of Voice over Broadband (VOB), access.

In the Internet services sector, Bezeq International provides Internet access services for private and business customers, including terminal equipment and support, with an emphasis on broadband Internet based on asymmetric digital subscriber lin e (ADSL) or cable infrastructures; hosting services site storage and server services in a designated installation for business and private customers, including value-added services (such as monitoring and control); information security services, services securing customers Internet and local area network (LAN) connections using the required terminal equipment or software, including monitoring; data services with international data communication IP solutions for business customers, including global deployment if necessary, and wireless fidelity (WIFI) access fast wireless access solutions for private and business customers, including in various public locations (hotspots).

Bezeq International supplies of international data communication solutions for business customers, including customized global deployment. As part of the service contracts, Bezeq International supplies direct maintenance of a range of exchange manufactur! ers. The ! services are given to gateways, exchanges and NEP designated for use with both internal and ! external ! lines. As part of business information technology (IT) solutions, Bezeq International provides communications services, including data and overseas communication services, server and Website hosting services, technical maintenance and support services, networking and system services, outsourcing and out-tasking services, security and risk management solutions and IP based services. Bezeq also provides ICT solutions to business customers as part of an overall ICT solution for businesses. Bezeq International provides broad communications services, including international data and communication services, server and site hosting services, technical support and maintenance services, network and system services, outsourcing and out-tasking services, security and risk management solutions and managed IP services.

DBS

DBSs broadcasts approximately 150 different video channels, of which 14 are pay-per-view (PPV) channels and 19 are high definition (HD), c hannels, 20 radio channels, 30 music channels and interactive services. The broadcasts include a basic package which each subscriber is required to purchase as well as additional channels chosen by the subscriber, whether as a package or as single and PPV channels. The main channel packages marketed by DBS in addition to the basic package are the movie, entertainment, children's, music, sports, science and nature packages. DBS also has a content Website which is operated together with Walla! which allows viewing of various forms of content, some of them at a fee. DBS markets personal video recorder (PVR), decoders which interface with DBSs electronic broadcast schedule and enable receipt of special services, including ordering recordings in advance, recording series and pausing live broadcasts. DBS also provides its subscribers with HD broadcasts, which can be received through special decoders.

The Company competes! with Cel! lcom Israel Ltd., or Cellcom, Partne r. 013 Netvision, 012 Smile, 018 Xfone, HILAT Israel Telecom! municatio! ns Company Ltd., and Telzar International Communication Services Ltd.

Advisors' Opinion:
  • [By Alexis Xydias]

    Brokerages are beating banks and the broader market in Europe. The Stoxx 600 Financial Services Index has gained 12 percent this year, more than twice the 5.6 percent advance for a gauge of European banks. Hargreaves Lansdown Plc (HL/), the U.K.s largest retail broker, which received record cash in its latest quarter, according to an April 17 statement, advanced 33 percent. IG Group Holdings Plc (IGG), the London-based provider of spread betting, rose 30 percent.

  • source from Top Penny Stocks For 2015:http://www.topstocksforum.com/top-10-telecom-stocks-to-watch-right-now.html

Saturday, June 28, 2014

Top 5 Chemical Companies To Own For 2014

Since today�� specialty chemicals industry supplies most finished goods manufacturers, the economic and consumer recession had a direct impact on this particular industry�� results since the end of 2009. Eastman Chemical Company (EMN) wasn�� the exception. The firm has made an emphasis on its acetate tow production, mainly used for cigarettes. The company stands out for using coal as its input, in contrast with other competitors using petroleum and gas, both more expensive for production. This mark up has allowed Eastman to transfer some of its increasing costs onto prices, �without compromising its sales revenue.

In addition to this, the acquisition of Solutia Inc. (former global leader in performance materials) completed on July 2, 2012, broadened Eastman�� specialty chemicals output by adding automotive and solar end products to its portfolio.

Although Eastman is a highly diversified company, it has proven to be severely affected by negative cycles of the economy. Even though this feature is not appealing whatsoever to investments, it certainly has caused it to become a cheap alternative. And, a quite promising one, since the economic recovery boosted its revenue, as a result of Eastman�� focus on cost-advantage production methods.

Best Biotech Stocks To Own Right Now: Stepan Co (SCL)

Stepan Company, incorporated on February 19, 1959, produces specialty and intermediate chemicals, which are sold to other manufacturers and then made into a variety of end products. The Company serves principal markets, such as manufacturers of cleaning and washing compounds (including detergents, shampoos, fabric softeners, toothpastes and household cleaners), paints, cosmetics, food and beverages, agricultural products, plastics, furniture, automotive equipment, insulation and refrigeration. The Company has three segments: surfactants, polymers and specialty products. The Company operates in the geographical regions of North America, Europe, Latin America and Asia. As of December 31, 2012, the Surfactants segment accounted to 72%, Polymers segment accounted to 24% and Specialty segment accounted to 4% of the Company�� revenues. On March 22, 2012, the Company increased its controlling interest in Stepan Philippines Inc from 89% to 100%.

Surfactants

Surfactants are used in a variety of consumer and industrial cleaning compounds as well as in agricultural products, lubricating ingredients, biodiesel and other specialized applications. The Surfactants are principal ingredients in consumer and industrial cleaning products, such as detergents for washing clothes, dishes, carpets, floors and walls, as well as shampoos, body washes, toothpastes and fabric softeners. Surfactants are manufactured at six North American sites (five in the United States and one in Canada), three European sites (United Kingdom, France and Germany), and three Latin American sites (Mexico, Brazil and Colombia), and one Asian site (Philippines and Singapore). The Company also holds a 50% ownership interest in a joint venture, TIORCO, LLC (TIORCO), that markets chemical solutions for increasing the production of crude oil and natural gas from existing fields.

Polymers

Polymers generate its revenues primarily from the sale of polyols and phthalic anhydride used in plastics, buildi! ng materials and refrigeration systems. It includes two primary product lines: polyols and phthalic anhydride. Polyols are used in the manufacture of rigid laminate insulation board for thermal insulation in the construction industry. Polyols are also a base raw material for flexible foams, coatings, adhesives, sealants and elastomers.

Phthalic anhydride is used in unsaturated polyester resins, alkyd resins and plasticizers for applications in construction materials and components of automotive, boating and other consumer products. In addition, phthalic anhydride is used internally in the production of polyols. In the United States, polymer product lines are manufactured at the Company�� Millsdale, Illinois, site. In Europe, polyols are manufactured at the Company�� subsidiaries in Germany and Poland. In Asia, polyols are produced at the Company�� 80% owned joint venture in Nanjing, China.

Specialty Products

Specialty products are used in food, flavoring and pharmaceutical applications. It includes flavors, emulsifiers and solubilizers used in the food and pharmaceutical industries. Specialty products are primarily manufactured at the Company�� Maywood, New Jersey, site.

Advisors' Opinion:
  • [By Marc Bastow]

    Specialty chemical maker Stepan (SCL) raised its quarterly dividend 6% to 17 cents per share, payable on Dec. 13 to shareholders of record as of Nov. 29. This marks the 46th consecutive annual dividend increase.
    SCL Dividend Yield: 1.13%

  • [By Seth Jayson]

    Basic guidelines
    In this series, I examine inventory using a simple rule of thumb: Inventory increases ought to roughly parallel revenue increases. If inventory bloats more quickly than sales grow, this might be a sign that expected sales haven't materialized. Is the current inventory situation at Stepan (NYSE: SCL  ) out of line? To figure that out, start by comparing the company's inventory growth to sales growth. How is Stepan doing by this quick checkup? At first glance, not so great. Trailing-12-month revenue decreased 4.8%, and inventory increased 30.6%. Comparing the latest quarter to the prior-year quarter, the story looks potentially problematic. Revenue dropped 1.9%, and inventory grew 30.6%. Over the sequential quarterly period, the trend looks OK but not great. Revenue grew 6.9%, and inventory grew 9.5%.

  • [By Monica Gerson]

    Stepan Company (NYSE: SCL) is expected to report its Q3 earnings at $0.93 per share on revenue of $467.40 million.

    Lennox International (NYSE: LII) is projected to report its Q3 earnings at $1.28 per share on revenue of $877.87 million.

Top 5 Chemical Companies To Own For 2014: American Vanguard Corp (AVD)

American Vanguard Corporation, incorporated on January 2, 1969, operates as a holding company. The Company is primarily a chemical manufacturer that develops and markets products for agricultural and commercial uses. The Company manufactures and formulates chemicals for crops, human and animal protection. The Company conducts its business through its subsidiaries, AMVAC Chemical Corporation (AMVAC), GemChem, Inc. (GemChem), 2110 Davie Corporation (DAVIE), Quimica Amvac de Mexico S.A. de C.V. (AMVAC M), AMVAC de Costa Rica Sociedad Anonima (AMVAC CR), AMVAC Switzerland GmbH (AMVAC S), AMVAC do Brasil Representacoes Ltda (AMVAC B), AMVAC Chemical UK Ltd. (AMVAC UK), AMVAC CV (AMVAC CV), AMVAC Netherlands BV (AMVAC BV), and Envance Technologies, LLC (Envance). In July 2012, the Company completed the restructuring of the International Sales & Marketing function of its principal operating subsidiary, AMVAC Chemical Corporation. On November 30, 2012, AMVAC and TyraTech, Inc. formed Envance Technologies, LLC, in which the Company owns 60% of the equity interest. In July 2012, the Company formed AMVAC CV and AMVAC BV.

AMVAC is a chemical manufacturer that develops and markets products for agricultural and commercial uses. It manufactures and formulates chemicals for crops, human and animal health protection. These chemicals, which include insecticides, fungicides, herbicides, molluscicides, growth regulators, and soil fumigants, are marketed in liquid, powder, and granular forms. AMVAC owns and/or operates the Company�� domestic manufacturing facilities and is also the parent company for all its foreign companies. DAVIE owns real estate for corporate use.

GemChem is a national chemical distributor. GemChem, in addition to purchasing key raw materials for the Company, also sells into the pharmaceutical, cosmetic and nutritional markets. GemChem is a wholly owned subsidiary of AVD.

Advisors' Opinion:
  • [By Seth Jayson]

    Calling all cash flows
    When you are trying to buy the market's best stocks, it's worth checking up on your companies' free cash flow once a quarter or so, to see whether it bears any relationship to the net income in the headlines. That's what we do with this series. Today, we're checking in on American Vanguard (NYSE: AVD  ) , whose recent revenue and earnings are plotted below.

Top 5 Chemical Companies To Own For 2014: Calgon Carbon Corp (CCC)

Calgon Carbon Corporation is a provider of products, services, and solutions for purifying water and air. The Company operates in three reportable segments: Activated Carbon and Service, Equipment, and Consumer. The Activated Carbon and Service segment manufactures granular and powdered activated carbon for use in applications to primarily remove organic compounds from water, air and other liquids and gases. The service aspect of the segment consists of reactivation and the leasing, monitoring and maintenance of carbon adsorption equipment. The Equipment segment provides solutions to customers��air and water purification problems through the design, fabrication, installation, and sale of equipment systems that utilize a combination of the Company�� enabling technologies: carbon adsorption, ultraviolet light (UV), Ballast Water Treatment (BWT), and advanced ion exchange separation (ISEP). The Consumer segment primarily consists of the manufacture and sale of carbon cloth. On March 31, 2011 the Company completed the acquisition of Calgon Carbon Japan KK (CCJ).

Activated Carbon and Service

The sale of activated carbon is the principle component of the Activated Carbon and Service business segment. Activated carbon is a porous material that removes organic compounds from liquids and gases by a process known as adsorption. In adsorption, unwanted organic molecules contained in a liquid or gas are attracted and bound to the surface of the pores of the activated carbon as the liquid or gas is passed through. The primary raw material used in the production of the Company�� activated carbons is bituminous coal which is crushed, sized and then processed in low temperature kilns followed by high temperature furnaces. The Company also markets activated carbons from other raw materials, including coconut shell and wood. The Company produces and sells a range of activated, impregnated or acid washed carbons in granular, powdered or pellet form. Granular activated carbon (GAC) particl! es are irregular in shape and generally used in fixed filter beds for continuous flow purification processes.

Another component of the Activated Carbon and Service business segment are the optional services associated with supplying the Company�� products and systems required for purification, separation, concentration, taste and odor control. The Company offers a variety of treatment services at customer facilities, including carbon supply, equipment leasing, installation and demobilization, transportation and spent carbon reactivation. Other services include feasibility testing, process design, performance monitoring and maintenance of Company-owned equipment. The central component of the Company�� service business is reactivation of spent carbon and re-supply. The Company provides reactivation/recycling services in packages ranging from a 55 gallon drum to truckload quantities.

Equipment

Along with providing activated carbon products, the Company has developed a portfolio of standardized, pre-engineered, adsorption systems capable of treating liquid flows from 1 gallons per minute to 1,400 gallons per minute, which can be delivered and installed at treatment sites. These self-contained adsorption systems are used for vapor phase applications, such as volatile organic compound (VOC) control, air stripper off-gases, and landfill gas emissions. Liquid phase equipment systems are used for applications of potable water, process purification, wastewater treatment, groundwater remediation and de-chlorination. The Company produces a range of odor control equipment, which typically utilizes catalytic activated carbon to control odors at municipal wastewater treatment facilities and pumping stations. The Company�� variety of equipment systems treats the odors that emanate from municipal wastewater treatment facilities and the sewage collection systems that bring the waste to the treatment plant.

The ISEP (Ionic Separator) continuous ion exchange units ! are used ! for the purification and recovery of many products in the food, pharmaceutical, and biotechnology industries. The ISEP Continuous Separator units perform ion exchange separations using countercurrent processing. The ISEP and CSEP (chromatographic separator) systems are used at over 300 installations worldwide in more than 40 applications in industrial settings, as well as in environmental applications, including perchlorate and nitrate removal from drinking water. The Hyde GUARDIAN System was developed as a chemical-free, International Maritime Organization (IMO) type approved, ballast water management solution. The system is designed to meet the needs of ship owners to install treatment system.

Consumer

The primary product offered in the Consumer segment is carbon cloth. Carbon cloth, which is activated carbon in cloth form, is manufactured in the United Kingdom and sold to the medical, military, and specialty markets. Zorflex Activated Carbon Cloth can be used in numerous additional applications, including sensor protection; filters for ostomy bags; wound dressings; conservation of artifacts, and respiratory masks.

The Company competes with Norit, N.V., Mead/Westvaco Corporation, Siemens Water Technologies, Trojan Technologies, Inc., Xylem, Wedeco Ideal Horizons, Panasia, Alfa Lavel Tumba AB, Hyde Marine, Inc. and Wartsila.

Advisors' Opinion:
  • [By Inyoung Hwang]

    Computacenter Plc (CCC) slipped 4.5 percent to 543 pence, its biggest drop since June. UBS AG lowered the technology-services provider to neutral from buy, citing its valuation. The shares have climbed to 13.18 times estimated earnings from 11.81 times at the end of last year, according to data compiled by Bloomberg.

  • [By Aaron Levitt]

    Calgon Carbon Corporation (CCC) is one of the largest manufacturers of activated carbon and filtration systems in the world, with activated carbon capacity of around 75,000 tons per year. That�� a good position to be in, as carbon filters are some of the most effective methods at removing chlorine, sediment and other volatile organic compounds from wastewater. They are also one of the cheapest methods for utilities to implement.

Top 5 Chemical Companies To Own For 2014: National Oxygen Ltd (NOL)

National Oxygen Limited (NOL) is an India-based company, which is a producer and supplier of industrial gases both in liquid and gaseous forms to industries and hospitals. Its products include oxygen, nitrogen and acetylene. The Company operates in two segments: Industrial Gases, which is engaged in the manufacture of industrial gases, and Windmill, which is engaged in the generation of windmill energy. During the fiscal year ended March 31, 2012 (fiscal 2012), the Company produced 51,07,981 cubic meters of oxygen, 52,138 cubic meters of dissolved acetylene, 30,69,610 cubic meters of nitrogen and 26,86,762 kilowatt hours of windmill energy. It has two industrial gas plants in Tamil Nadu and Pondicherry, and one windmill in Maharashtra. During fiscal 2012, NOL had an installed capacity to produce 2,50,00,000 cubic meters of oxygen, 2,00,000 cubic meters of dissolved acetylene and 44,00,000 kilowatt hours of windmill energy. Advisors' Opinion:
  • [By John Emerson]

    Another huge benefit which was imbedded in the value of RTEC was the tens of millions of net operating losses (NOL) that the company had accrued as a result of the massive accrual losses it would sustain during the credit crisis. These benefits were not reflected on the balance sheet but they would translate into tens of millions of dollars in income tax savings when the company eventually returned to profitability.

Friday, June 27, 2014

Top 5 Beverage Stocks To Buy Right Now

Small cap Sodastream International Ltd (NASDAQ: SODA), an Israeli based developer, manufacturer and marketer of�home beverage carbonation systems, has attracted its share of hype over both its products and its stock, but could other small cap water stocks like Primo Water Corporation (NASDAQ: PRMW), Puresafe Water Systems Inc (OTCMKTS: PSWS) and Alkaline Water Company Inc (OTCBB: WTER) attract a similar following? After all, Sodastream International has managed to create a significant amount of buzz from consumers, investors and even short sellers because it�� the�world's largest manufacturer, distributor and marketer of home carbonation systems as its�brands are sold in over 60,000 retail stores in 45 countries. Sodastream International is also up 45.7% since the start of the year, up 70.2% over the past year and up 99.3% since November 2010, but shares did spike up to the $75 level in the middle of 2011 and now trade at the $63 level.

Best Dow Dividend Companies To Buy For 2015: Monster Beverage Corp (MNST)

Monster Beverage Corporation, formerly Hansen Natural Corporation, incorporated on April 25, 1990,is a holding company. The Company develops, markets, sells and distributes alternative beverage. The alternative beverage category combines non-carbonated ready-to-drink iced teas, lemonades, juice cocktails, single-serve juices and fruit beverages, ready-to-drink dairy and coffee drinks, energy drinks, sports drinks, and single-serve still water (flavored, unflavored and enhanced) with new age beverages, including sodas that are considered natural, sparkling juices and flavored sparkling beverages. It has two reportable segments, namely Direct Store Delivery (DSD), whose principal products comprise energy drinks, and Warehouse (Warehouse), whose principal products comprise juice-based and soda beverages. The DSD segment develops, markets and sells products primarily through an exclusive distributor network, whereas the Warehouse segment develops, markets and sells products primarily directly to retailers. Corporate and unallocated amounts that do not relate to the DSD or Warehouse segments specifically, have been allocated to Corporate and Unallocated.

During the year ended December 31, 2012, it continued to expand its existing product lines and flavors and further develop its distribution markets. In particular, it continued to focus on developing and marketing beverages that fall within the category generally described as the alternative beverage category. During the year ended December 31, 2012, it introduced a number of new products, including Monster Rehab Tea + Orangeade + Energy, a non-carbonated energy drink with electrolytes, Monster Energy Zero Ultra, a carbonated energy drink which contains zero calories and zero sugar, bermonster Energy Brew, a non-alcoholic energy drink, manufactured using a brewed fermentation process, Hansen�� Coconut Water, in original and tropical flavors, packaged in re-sealable Tetra Prisma boxes, Peace Tea Cranberry, Pink Lemonade and Texas-Style Sweet ! Tea, ready-to-drink iced teas, Monster Cuba-Lima, a carbonated lime flavored non-alcoholic energy drink, Monster Energy Dub Edition Baller�� Blend, a carbonated punch + energy drink and Monster Energy Dub Edition Mad Dog, a carbonated punch + energy drink.

DSD Segment

Monster Energy Drinks offers products under the Monster Energy drink product line: Monster Energy, Lo-Carb Monster Energy, Monster Energy Assault, Monster Khaos, Monster M-80 (named Ripper in certain countries), Monster MIXXD, Monster Energy Absolutely Zero, Monster Energy Import and Import Light, Monster Energy Dub Edition Baller�� Blend, Monster Energy Dub Edition Mad Dog, M3 Monster Energy Super Concentrate energy drinks, bermonster Energy Brew, Monster Energy Zero Ultra and Monster Cuba-Lima.

Java Monster Coffee + Energy Drinks - A line of non-carbonated dairy based coffee + energy drinks. It offers products under the Java Monster product line: Java Monster Kona Blend, Java Monster Loca Moca, Java Monster Mean Bean, Java Monster Vanilla Light, Java Monster Irish Blend and Java Monster Toffee. Monster Energy Extra Strength Nitrous Technology Energy Drinks - A line of carbonated energy drinks containing nitrous oxide. It offer products under the Monster Energy Extra Strength Nitrous Technology product line: Super Dry, Anti Gravity and Black Ice.

-Presso Monster Coffee + Energy Drinks - A line of non-carbonated dairy based coffee + energy drinks. It offers products under the X-Presso Monster coffee + energy drinks product line: X-Presso Monster Hammer and X-Presso Monster Midnite.

Monster Rehab Tea + Energy Drinks - A line of non-carbonated energy drinks with electrolytes. It offers products under the Monster Rehab drink line: Monster Rehab Tea + Lemonade + Energy, Monster Rehab Rojo Tea + Energy, Monster Rehab Green Tea + Energy, Monster Rehab Protean + Energy and Monster Rehab Tea + Orangeade + Energy.

Worx Energy Energy Shots - A line of energy suppleme! nts which! contains zero calories and zero sugar. It offers products under the Worx Energy energy shot product line: Original Formula and Extra Strength.

Peace Tea Iced Teas - A line of ready-to-drink iced teas. It offers products under the Peace Tea product line: green tea, imported Ceylon tea, sweet lemon tea, razzleberry tea, cranberry tea, pink lemonade tea, Texas-style sweet tea and Caddy Shack tea + lemonade.

Warehouse Segment

Hansen�� brand sodas have been a natural soda brand on the West Coast of the United States for more than 30 years and are made with natural flavors. Hansen�� brand sodas, sweetened with cane sugar, and Hansen�� Diet Sodas, sweetened with Splenda no calorie sweetener and Acesulfame-K, contain no preservatives, sodium, caffeine or artificial colorings. It offers sodas under the Hansen�� brand name: Hansen�� Sodas, Hansen�� Diet Sodas and Hansen�� Natural Mixers, as well as Hansen�� Sparkling Waters, in a variety of flavors.

Its Blue Sky products contain no preservatives, artificial sweeteners, caffeine (other than its Blue Sky energy drinks) or artificial coloring and are made with sugar and natural flavors. It offers products under the Blue Sky product line: Blue Sky Natural Soda, Blue Sky Zero Calorie Sodas (sweetened with Truvia brand stevia extract, an all natural sweetener), Blue Sky Premium Sodas, Blue Sky Organic Natural Sodas, Blue Sky Seltzer Waters, Blue Sky Blue Energy drinks, Blue Sky Zero Calorie Blue Energy drinks, Blue Sky Caf Energy drinks and Blue Sky Recover Energy drinks.

Its original Hansen�� energy drinks compete in the functional beverage category, namely, beverages that provide a benefit in addition to simply delivering refreshment. It offers products under the Hansen�� energy drink product line: Hansen�� Natural Energy Pro, Hansen�� Energy Diet Red and Hansen�� Natural Stamina Pro.

Its fruit juice product line includes Hansen�� Natural Apple Juice, Ha! nsen�� ! Natural Grape Juice, White Grape Juice, Pineapple Juice, Apple Grape Juice, Apple Strawberry Juice, Orange Juice, Cranberry Juice, Cranberry-Apple Juice, Cranberry-Grape Juice, Ruby Red Grapefruit Juice, and Organic Apple Juice. In March 2012, it added Hansen�� Natural Apple Orange Pineapple Juice which contains 100% juice as well as 120% of the United States Recommended Daily Allowances (the USRDA) for vitamin C. It also offer Hansen�� Natural Lo-Cal juice cocktails, a line of all natural, low-calorie cocktails in four flavors. The Lo-Cal juice cocktails are sweetened with Truvia sweetener. Hansen�� juice products compete in the shelf-stable juice category.

It offers a number of aseptically packed boxed juice products, including its dual-branded multi-vitamin 100% juice line, which itsell in conjunction with Costco Wholesale Corporation (Costco) through Costco stores. It offers its Hansen�� Natural line of multi-vitamin 100% juices to other customers. These multi-vitamin juices contain eleven essential vitamins and six essential minerals and are available in a variety of flavors. In February 2012, it added Hansen�� Natural Organic Apple Juice, a 100% USDA Certified Organic Apple Juice with 100% of the USRDA for vitamin C.

Its Hansen�� Junior Juice product line is a 100% juice line targeted at toddlers and preschoolers. These juices have added calcium and all flavors contain 100% of the daily recommended allowance of vitamin C. It also offers organic juices as well as Hansen�� Organic Junior Water, a lightly flavored reduced calorie beverage, both of which contain 100% of the daily recommended allowance of vitamin C. In addition, it offers Junior Juice Coconut Water Twist, a line of fruit and coconut water juices containing 100% of the daily recommended allowance of vitamin C.

Its Hubert�� Lemonade is a line of premium ready-to-drink lemonades. Hubert�� Lemonade is sweetened with cane sugar and Truvia sweetener. Hubert�� Lemonade i! s all nat! ural and contains no preservatives, artificial sweeteners, caffeine, or artificial colorings. It offers products under the Hubert�� Lemonade product line: Strawberry Lemonade, Limeade, Mango Lemonade, Honey Lemonade, Raspberry Lemonade and Original Lemonade. It added Cherry Limeade and Blackberry Lemonade flavors to the product line in February 2012 and October 2012, respectively. In July 2012, it introduced 4-count multi-packs of select flavors.

Hubert�� Half & Half is sweetened with cane sugar and Truvia sweetener, and contains no preservatives, artificial sweeteners, or artificial colorings. Its Fruit and Tea Stix product line is an all-natural, low-calorie powder drink mix line, sweetened naturally with Truvia sweetener. Its Angeleno Aguas Frescas is a line of premium ready-to-drink aguas frescas. Angeleno Aguas Frescas are sweetened with cane sugar and real fruit juice and contain no preservatives, artificial sweeteners, caffeine, or artificial colorings. It offers flavors under the Angeleno Aguas Frescas product line: Mango, Melon, Pineapple, Jamaica (Hibiscus) and Tamarindo. Its Hansen�� Natural PRE products include a line of prebiotic and probiotic digestive wellness ready-to-drink beverages and powder drink mixes, containing specially formulated blends by Jarrow Formulas. PRE prebiotic ready-to-drink beverages are sweetened with either cane sugar or stevia. PRE probiotic powder drink mixes are sweetened with cane sugar and stevia. In March 2012, it introduced Hansen�� Natural Coconut Water, a line of premium 100% Coconut Waters available in Pure and Tropical flavors.

The Company competes with TCCC, PepsiCo, Inc. (PepsiCo), The Dr. Pepper Snapple Group, Inc. (the DPS Group), Red Bull Gmbh, Kraft Foods, Inc., GlaxoSmithKline plc, Nestle Beverage Company, Tree Top Inc. (Tree Top), Ocean Spray Cranberries Inc. (Ocean Spray), Red Bull, Rockstar, Full Throttle, No Fear, Amp, Adrenaline Rush, NOS, Venom, Redline, 180, Red Devil, Rip It, Xenergy, 5-Hour Energy ! Shots, Mi! O Energy, Stacker 2, VPX Redline Energy Shots, Red Bull, Rockstar, Burn, V-Energy, Lucozade, Adrenaline Rush, Power Play, Mother, Hell, Shock, Tiger, Boost, Gladiator, TNT, Shark, Hot 6, Nalu, Battery, Bullit, Flash Up, Black, Non-Stop, Bomba, Semtex, Starbucks Frappuccino, Starbucks Double Shot, Starbucks Double Shot Energy Plus Coffee , other Starbucks coffee drinks, Rockstar Roasted, Seattle�� Best, illy issimo coffee, Full Throttle Coffee, Arizona, Lipton, Snapple, Nestea, Xing Tea, Honest Tea, Gold Peak Tea, Fuze Tea, the DPS Group, Cott Corporation and National Beverage Corporation, Jones Soda Co., Crystal Geyser, J.M. Smucker Company, Reeds, Inc., Zevia, Tree Top, Mott��, Martinelli��, Welch��, Ocean Spray, Tropicana, Minute Maid, Langers, Apple , Eve, Seneca, Northland, Juicy Juice, Old Orchard, Calypso, Simply Lemonade, Minute Maid, Cabana, Tropicana, Newman�� Own, Vita Coco, ZICO and O.N.E.

Advisors' Opinion:
  • [By Ben Levisohn]

    Shares of Dr. Pepper (DPS) have been trouncing those of Coca-Cola (KO), PepsiCo (PEP) and even Monster Beverage (MNST) this year–but today it’s getting pounded thanks to a Citigroup downgrade.

Top 5 Beverage Stocks To Buy Right Now: Attitude Drinks Inc (ATTD)

Attitude Drinks Incorporated (Attitude), incorporated on May 10, 1988, is a brand-development company. The Company focuses on the non-alcoholic single serving beverage business, developing and marketing of milk based products in two segments: sports recovery and functional dairy. The Company does not directly manufacture its products but instead outsources the manufacturing process to third party packers.

Attitude has developed its second product, which is branded as Phase III Recovery is a milk-based protein drink which is available in chocolate and vanilla flavors. The Company�� co-packer for its dairy based product is O-AT-KA Milk Products Cooperative, Inc. in Batavia, New York. This product contains 35 grams of protein that are inherent in filtered milk. The product is packaged as a retort-processed shelf stable dairy-based 100% milk-based sports recovery drink in both chocolate and vanilla flavors.

The Company competes with The Coca-Cola Company and Pepsico Inc.

Advisors' Opinion:
  • [By Peter Graham]

    Small cap stocks Attitude Drinks Inc (OTCMKTS: ATTD), Axiologix, Inc (OTCMKTS: AXLX) and Unisource Corporation (OTCMKTS: USRC) have all been getting some attention lately in investment emails or investor alerts thanks in part to paid promotions. And while there is nothing wrong with properly disclosed paid promotions or investor relations activity, such activity can backfire on unwary investors or traders. With that in mind, here is a closer look at all three small cap stocks to help you decide whether they are truly hot or not:

Top 5 Beverage Stocks To Buy Right Now: Alkaline Water Company Inc (WTER)

The Alkaline Water Company Inc., formerly Global Lines Inc, incorporated on June 6, 2011, is a developer of electrolysis beverage process, packaged and branded as Alkaline84. Alkaline84 is the Company's flagship product designed to encourage daily consumption of Alkaline Water through a consumer oriented bulk delivery system. The Company is engaged in the development of a national retail bulk distribution network delivering Electrochemically Activated Water (ECA) to consumers everywhere. The Company is focused on the business of distributing and marketing the retail sale of its packaged Alkaline84 branded beverage products.

Alkaline84 is available in two sizes: three liters and one gallon. Alkaline84 is a pH balanced bottled alkaline drinking water enhanced with 84 trace minerals and electrolytes. Alkaline84 is available for consumer sales at a number of major retail locations across the southwestern United States.

Advisors' Opinion:
  • [By Bryan Murphy]

    PepsiCo, Inc. (NYSE:PEP), consider your dominance in the bottled water arena - via Aquafina - under a serious attack. And for The Coca-Cola Company (NYSE:KO), well, your Dasani brand's #2 position in the market share race isn't as secure as you'd like it to be either. There's a new name in town you need to watch out for - Alkaline Water Company Inc. (OTCBB:WTER). This young company is hungry... well, thirsty, and with its impressive product already making a big splash in the few markets its been introduced to, WTER is not only positioned to make a dent in the bottled water revenue being generated by the likes of KO and PEP, this little company may be serving up some solid gains for its investors as well.

  • [By Bryan Murphy]

    If you've lost count of how many distributors Alkaline Water Company Inc. (OTCBB:WTER) has working for it now, you're not alone. Ditto for the number of grocers that are offering its flagship produce... one-gallon bottles of Alkaline84 water (some of the best-tasting and healthiest spring water you could ever drink). So many distributors and grocery store chains have just started carrying Alkaline84 within the past two months that it's been nearly impossible to keep up with how quickly WTER has gotten its ball rolling. There is one thing that's clear though - Alkaline Water Company has a LOT of momentum right now, up from none at the beginning of July. Take a look at all the doors the company has opened since it actually began marketing its bottled water:

  • [By Bryan Murphy]

    Look out Primo Water Corporation (NASDAQ:PRMW), there's a serious threat nipping out your heels, and there way of "doing bottled water" may be a heck of a lot easier for consumers to swallow than your way. The name of that budding competition? Alkaline Water Company Inc. (OTCBB:WTER). In fact, WTER became just a little more competitive on Tuesday thanks to widening its reach.... again.

Top 5 Beverage Stocks To Buy Right Now: Molson Coors Brewing Company(TAP)

Molson Coors Brewing Company brews, markets, sells, and distributes beer brands. It sells its products in Canada, under the Coors Light, Molson, Rickard's Red, Carling, Pilsner, Keystone Light, Creemore Springs, and Granville Island brands. The company also brews or distributes products under license from third parties, which include Heineken, Amstel Light, Murphy's, Asahi, Asahi Select, Miller Lite, Miller Genuine Draft, Miller Chill, Milwaukee's Best, Milwaukee's Best Dry, and Foster's. In addition, it imports, distributes, and markets the Corona, Coronita, Negra Modelo, and Pacifico brands, through a joint venture agreement with Grupo Modelo. Further, the company sells various brands in the United States, which include Coors Light, Miller Lite, Coors Banquet, Miller Genuine Draft, MGD 64, Miller Chill, Sparks, Miller High Life, Miller High Life Light, Keystone Light, Icehouse, Mickey's, Milwaukee's Best, Milwaukee's Best Light, Old English 800, Blue Moon, Henry Weinhard 's, George Killian's Irish Red, Leinenkugel's, Peroni Nastro Azzurro, Pilsner Urquell, Grolsch, Coors Non-Alcoholic, and Sharp's. Additionally, it sells various brands in the United Kingdom comprising Carling, C2, Coors Light, Worthington's, White Shield, Caffrey's, Kasteel Cru, and Blue Moon, as well as various regional ale brands. The company also sells the Grolsch brands through a joint venture with Royal Grolsch N.V. and the Cobra brands through a joint venture called Cobra Beer Partnership Ltd.; and distributes brands sold under license, including Corona, Coronita, Negra Modelo, Pacfico, Singha, and Magners Draught Cider. In addition, it markets and sells Zima, Si'hai, Coors Gold, and Coors Extra brands to various international markets. The company was formerly known as Adolph Coors Company and changed its name to Molson Coors Brewing Company as a result of its merger with Molson Inc. in February 2005. Molson Coors Brewing Company was founded in 1873 and is headquartere d in Denver, Colorado.

Advisors' Opinion:
  • [By Alex Planes, Sean Williams, and Travis Hoium]

    Things haven't been too much better on the beer front, with both domestic giant Anheuser-Busch InBev (NYSE: BUD  ) and Molson Coors (NYSE: TAP  ) looking abroad to make deals. With pocketbooks clenched tight as higher taxes and a slow recovery drain the American consumer, Anheuser-Busch took to purchasing Grupo Modelo's international operations, while Molson Coors gobbled up Eastern Europe's StarBev in a $3.5 billion transaction last year to get their share of faster emerging-market growth. Diageo is attempting to find new pathways to growth as well, but it's approaching things from a distilling angle by attempting to become a majority stakeholder in India's largest distiller, United Spirits.

Wednesday, June 25, 2014

Hot Logistics Stocks For 2014

Top 5 European Companies To Own In Right Now


Ford's Joe Hinrichs presented the EcoSport SUV at last year's Auto China show. The EcoSport, one of several Ford SUVs set to debut in China, will arrive at Ford's Chinese dealers later this spring. Photo credit: Ford Motor Company

Analysts were surprised a few years back when the scale of Ford's (NYSE: F  ) ambitious plans for China first became clear.

For a while, the Blue Oval's plans to spend almost $5 billion on new factories and roll out 15 new models by 2015 seemed... not far-fetched, exactly, but more than ambitious. Audacious, maybe.

Preoccupied with its problems at home, the Blue Oval had stood by while global archrivals General Motors (NYSE: GM  ) and Volkswagen (NASDAQOTH: VLKAY  ) carved out commanding positions in the Chinese market over the last decade, with Toyota (NYSE: TM  ) not far behind.

Best High Tech Companies To Invest In Right Now: Dollar Tree Inc.(DLTR)

Dollar Tree, Inc. operates discount variety stores in the United States and Canada. Its stores offer merchandise primarily at the fixed price of $1.00. The company operates its stores under the names of Dollar Tree, Deal$, Dollar Tree Deal$, Dollar Giant, and Dollar Bills. Its stores offer consumable merchandise, including candy and food, and health and beauty care, as well as household consumables, such as paper, plastics, household chemicals, in select stores, and frozen and refrigerated food; variety merchandise, which includes toys, durable housewares, gifts, party goods, greeting cards, softlines, and other items; and seasonal goods, such as Easter, Halloween, and Christmas merchandise. As of April 30, 2011, it operated 4,089 stores in 48 states and the District of Columbia, as well as 88 stores in Canada. The company was founded in 1986 and is based in Chesapeake, Virginia.

Advisors' Opinion:
  • [By John Maxfield]

    If you're anything like me, two things went through your head when you saw this. First, you regret that you missed out on the investment opportunity. Since the end of 2009, shares in all three of these companies, led by Dollar Tree (NASDAQ: DLTR  ) , have simply trounced the broader market. Even the worst performer of the bunch, Family Dollar (NYSE: FDO  ) , beat it by nearly a factor of two.

Best High Tech Companies To Invest In Right Now: Bayer AG (BAYRY)

Bayer AG is a management holding company. The Company�� business operations are organized into three subgroups: HealthCare, CropScience and MaterialScience, supported by the service companies Bayer Business Services, Bayer Technology Services and Currenta. Bayer HealthCare is involved in the research, development and manufacture of health products for people and animals. Bayer CropScience is engaged in the crop protection and non-agricultural pest control. Bayer MaterialScience supplies polymers, and develops solution for a range of applications. In November 2009, Bayer MaterialScience acquired the polymer coatings business from Lombard Medical Technologies PLC. On November 2, 2009, it acquired Athenix Corporation. On October 1, 2009, it acquired two dermatology product lines from SkinMedica, Inc., Carlsbad, California, United States. On June 25, 2009, it acquired the remaining 10% interest in Bayer Polymers (Shanghai) Co. Ltd., China. In May 2009, it acquired the remaining 49% interest in Berlimed, s.a., Spain, from Juste s.a. Quimica Farmac茅utica (Juste), and in return sold its 51% interest of Justesa Imagen, s.a., Spain, to Juste. In May 2009, it also sold the Thermoplastics Testing Center, Krefeld, Germany, to Underwriters Laboratories Inc. In March 2010, the Company announced that its Bayer MaterialScience LLC has acquired Artificial Muscle, Inc, a company active in electroactive polymers for the consumer electronics industry.

Bayer HealthCare

The Company researches, develops, manufactures pharmaceutical and medical products. Bayer HealthCare operates in four operating divisions: Animal Health, which is engaged in manufacture of veterinary medicines and grooming products; Bayer Schering Pharma, which is engaged in manufacture of prescription medicines; Consumer Care, which is engaged in the manufacture of over-the-counter medicines and dietary supplements, and Medical Care, which is engaged in manufacture of blood glucose monitoring devices and contrast agent injecti! on systems. Its products for farm animals include Baytril. Its products for companion animals include Advantage/Advantix and Baytril. Its drug discovery in the pharmaceuticals segment focuses on the areas of cardiology, oncology,

women�� healthcare and diagnostic imaging.

Bayer CropScience

CropScience maintains a global network of research and development facilities. In the Crop Protection segment it identifies and develops safe and economically sustainable insecticides, fungicides and herbicides and carries its research projects in areas, such as plant health or stress tolerance. As of December 31, 2009, its active ingredient pipeline of Crop Protection contained 20 development projects, of which 10 was at an advanced stage and 10 at an early stage of development, and an additional 45 projects was undergoing early-stage research. Its operations are structured into six business operations units: four regional Crop Protection units plus the Environmental Science and BioScience units. Its insecticides include Confidor/ Admire, Calypso, Decis, Temik and Oberon. Its fungicides include Antracol, Fandango, Flint/Stratego/Sphere/Twist, Folicur and Previcur Energy. Its herbicides include Atlantis, Basta, Betanal, Fenikan, Hoestar, Husar, MaisTer, Puma. Its seed treatment products include Bariton, Gaucho, Lamarador, Poncho and Raxil.

Bayer MaterialScience

The Company supplies materials, such as polycarbonates and polyurethanes and system solutions for a range of everyday uses. It operates in three business units: Polyurethanes, Polycarbonates, and Coatings, Adhesives and Specialties. Its Coatings, Adhesives, Specialties producst include Desmodur, Bayhydur, Dispercoll and Artwalk. Its Polycarbonates include Makrolon, Makrofol / Bayfol, Fantasia and Bayblend. Its Polyurethanes include Multitec, Baydur, Bayflex, Baypreg and Vulkollan. Its Thermoplastic Polyurethanes include Desmopan / Texin.

Advisors' Opinion:
  • [By Monica Gerson]

    Breaking news

    Quest Diagnostics (NYSE: DGX) today announced that it has entered into a definitive purchase agreement under which Quest will acquire Summit Health. Terms of the transaction were not disclosed. To read the full news, click here. Bayer HealthCare Pharmaceuticals (OTC: BAYRY) and Onyx Pharmaceuticals, an Amgen subsidiary (NASDAQ: AMGN), today announced that a Phase 3 trial evaluating the investigational use of NEXAVAR庐 (sorafenib) tablets as an adjuvant treatment for patients with hepatocellular carcinoma (HCC), or liver cancer, who had no detectable disease after surgical resection or local ablation, did not meet its primary endpoint of improving recurrence-free survival. To read the full news, click here. Barrick Gold (NYSE: ABX) today announced that, further to its release of March 10, 2014, it has completed the divestment of 41.0 million ordinary shares in African Barrick Gold plc, representing in aggregate approximately 10.0 percent of the issued ordinary share capital of ABG, at a price of 275 pence per ordinary share, raising gross proceeds of approximately GBP 113 million (US$188 million). To read the full news, click here. Urban Outfitters (NASDAQ: URBN) dropped in after-hours trading after the company released its fourth quarter results. The firm reported a Q4 EPS of $0.59 versus the Street estimate of $0.55. To read the full news, click here.

    Posted-In: Pacific Crest US Stock FuturesNews Eurozone Futures Global Pre-Market Outlook Markets

  • [By Sean Williams]

    Another big beneficiary from type 1 diabetes is glucose-monitoring device makers. Perhaps the most exciting product in this space is Bayer's (NASDAQOTH: BAYRY  ) Contour Next Link. Bayer has partnered its device with Medtronic (NYSE: MDT  ) in such a way that it'll connect wirelessly to Medtronic's insulin pump, drastically reducing many instances of human error or forgetfulness, and delivering the right dosage of insulin to patients throughout the course of the day.

  • [By Dan Carroll]

    If investors want to find the best German stocks, they should look for the most global firms. Take Bayer (NASDAQOTH: BAYRY  ) , for example. The German chemical and pharmaceutical maker has pivoted toward globalization in order to counteract Europe's crunch, which has slammed hospital budgets and health care spending. Bayer recently picked up a majority stake in California-based birth-control maker Conceptus -- a buy that capitalizes on Bayer's own birth control business -- and the firm's North American business has surged recently, posting a 17% revenue gain in 2012. Meanwhile, Bayer's European sales flattened last year. Geographic diversity will win the day for Germany's top stocks, and Bayer's shares have pulled in double-digit gains year-to-date.

  • [By Sean Williams]

    So what: In midday trading, AVEO and development partner Astellas Pharma reported that the FDA panel had voted 13-1 that Tivozanib had not demonstrated a favorable benefit-to-risk evaluation in treating advanced kidney cancer. AVEO's CEO, Tuan Ha-Ngoc, noted his discouragement with the FDA panels' findings, but plans to work closely with the FDA to improve upon what it felt Tivozanib lacked. If you recall, Tivozanib demonstrated a statistically significant progression-free survival benefit over Onyx Pharmaceuticals (NASDAQ: ONXX  ) and Bayer's (NASDAQOTH: BAYRY  ) Nexavar in trials, but fell short of Nexavar in terms of median overall survival, which perplexed many.

Hot Companies To Buy Right Now: Performance Technologies Incorporated(PTIX)

Performance Technologies, Incorporated manufactures and supplies network communications solutions to carrier, government, defense, and original equipment manufacturer (OEM) markets. The company offers a suite of SEGway signaling solutions, including IP-centric STPs, gateways, edges, and network applications that provide signaling, routing, IP migration, gateway capabilities, SIP bridging, and core-to-edge distributed intelligence. It also provides IPnexus application-ready systems, which are IP-native integrated platforms and element management systems; Xpress, a portfolio of SIP-based applications and enabling infrastructure for next-generation network architectures; and universal signaling point and SP2000 products. The company markets its products through its direct sales forces, as well as through OEMs, value added resellers, distributors, and systems integrators worldwide. Performance Technologies, Incorporated was founded in 1981 and is headquartered in Rochester, Ne w York.

Advisors' Opinion:
  • [By Ben Fox Rubin]

    Sonus Networks Inc.(SONS) agreed to buy Performance Technologies Inc.(PTIX), a supplier of network communications products, for $3.75 a share, a 26% premium of Thursday’s close, or $42 million. The companies said the deal was worth $30 million, net of Performance Technologies’ cash and excluding acquisition costs. Performance Technologies shares jumped 24% to $3.70 premarket, just under the offer price.

Best High Tech Companies To Invest In Right Now: CytRx Corporation(CYTR)

CytRx Corporation, a biopharmaceutical research and development company, engages in the development of human therapeutics, specializing in oncology. Its drug development pipeline includes INNO-206, which is in Phase II clinical trials for the treatment of soft tissue sarcomas and is in Phase Ib/2 clinical trials for the treatment of solid tumors; and tamibarotene that is in Phase II clinical trials for the treatment of non-small-cell lung cancer and acute promyelocytic leukemia. The company also develops Bafetinib, which is in Phase II clinical trials for the treatment of B-cell chronic lymphocytic leukemia and advanced prostate cancer, as well as in pharmacokinetic clinical trial for brain cancer. CytRx Corporation was founded in 1985 and is headquartered in Los Angeles, California.

Advisors' Opinion:
  • [By Bryan Murphy]

    If you're reading this, then odds are you already know that small caps WidePoint Corporation (NYSEMKT:WYY), CytRx Corporation (NASDAQ:CYTR), and Elephant Talk Communications Corp. (NYSEMKT:ETAK) are among the recent big winners from the small cap stock realm. ETAK is up 100% since the end of October, largely spurred by encouraging numbers in its third-quarter results. CYTR shares have rallied more than 150% in just the past three days on the heels of an announcement that a cancer drug the biotech company is developing has shown wonderful Phase 2 results. And, WYY has advanced 93% over the past month or so, thanks to Q3's earnings announcement, though the trading public - and then the media - certainly took the ball and ran with it.

  • [By James Johnson]

    CytRx Corporation's (NASDAQ: CYTR  ) oncology drug, aldoxorubicin, an improved version of the chemotherapeutic agent doxorubicin, recently received FDA approval to extend the dosing in a Phase 3 clinical trial. This trial is evaluating aldoxorubicin as a second-line treatment for soft-tissue sarcomas (STS). In April 2013, the FDA granted Special Protocol Assessment (SPA) to aldoxorubicin as a second-line treatment for STS with a maximum dosing of six cycles. The drug is given by a 30 minute IV infusion once every three weeks which is one cycle. The extension of the treatment cycle was based on aldoxorubicin's superior cardiac safety and efficacy profile compared to doxorubicin in prior studies. Aldoxorubicin was found to be safer than doxorubicin, a toxic drug associated with side effects such as cardiovascular events and heart damage in cancer patients. The extended dosing could allow CytRx to demonstrate even higher progression-free survival (PFS) efficacy results compared to the Phase 2b trial for advanced STS with this drug. The company plans to initiate the Phase 3 trial during the first quarter of 2014.

  • [By John Udovich]

    Small cap biotech stock�CytRx Corporation (NASDAQ: CYTR) started the new year jumping 10.05% for an almost 50% rise over the past week or so after it surged 68.2% in one day in early�December, meaning it might be time to take a closer look at the stocks along with the performance of biotech ETF benchmarks like the�iShares NASDAQ Biotechnology Index ETF (NASDAQ: IBB) and SPDR S&P Biotech ETF (NYSEARCA: XBI). I should mention that we have recently added CytRx Corporation to our SmallCap Network Elite Opportunity (SCN EO) portfolio since December 20th and we are up around 49% since then.

  • [By Bryan Murphy]

    They say it's darkest just before dawn. If that's true for stocks - and it usually is - the now may be the time to wade into CytRx Corporation (NASDAQ:CYTR).

Best High Tech Companies To Invest In Right Now: Scholastic Corporation(SCHL)

Scholastic Corporation, together with its subsidiaries, operates as a children?s publishing, education, and media company primarily in the United States. The company?s Children?s Book Publishing and Distribution segment publishes and distributes children?s books through school-based book clubs and book fairs, ecommerce, and the trade channel in the United States. Its Educational Publishing segment publishes and distributes educational technology products and services, curriculum materials, children?s books and collections, classroom magazines, and print and online reference and non-fiction products for grades pre-K to 12 to schools and libraries in the United States. The company?s Media, Licensing, and Advertising segment creates and produces programming and digital content for various platforms, including television, DVDs, audio, movies, interactive games, applications, and Websites. This segment produces and sells a television library consisting of approximately 50 0 half-hour productions; produces television programming, including the animated series; creates audiovisual adaptations of classic children?s picture books; produces young adult and children?s audio recordings; and creates original and licensed consumer software, including handheld and console products with accessories and mobile applications for grades pre-K to 8. This segment also develops sponsored educational materials and supplementary classroom programs in partnership with government agencies, nonprofit organizations, and business organizations; and operates a direct-to-home catalog business specializing in children?s toys. Its International segment publishes and distributes products and services in Canada, the United Kingdom, Australia, New Zealand, Ireland, India, China, Singapore, and other parts of Asia, as well as includes its export and foreign rights businesses. Scholastic Corporation was founded in 1920 and is headquartered in New York, New York.

Advisors' Opinion:
  • [By Dividends4Life]

    Scholastic Corporation (SCHL) operates as a children�� publishing, education, and media company in the United States and internationally. Sept. 18, the company increased its dividend 20% to $0.15 per share. The dividend is payable Dec. 16, 2013 to all shareholders of record as of the close of business on Oct. 31, 2013. The yield based on the new payout is 2.0%.

Best High Tech Companies To Invest In Right Now: Portlogic Systems Inc (PGSY)

Portlogic Systems Inc. (Portologic), incorporated on June 22, 2004, is a development-stage company. The Company is engaged in developing and licensing portal software products and related services. The Company operates six divisions, including m2Meet, m2Bank (Mobile to Bank), m2Market, m2Ticket, m2Kiosk and m2Workflow. The Company has developed a product that it licensed to its customers to enable them to operate their own online social networking portal without requiring any technical programming or Website design skills. The Company licenses portal software products and provide custom software programming services to customers who license its products. The Company�� portal software products are designed to enable customers to administer a ��ortal��that can be accessed online by other users. Each type of portal that it licenses to customers has a standard pre-programmed functional framework along with content and appearance customized according to the customer�� particular requirements. The Company�� customers retain ownership rights over any content that they provide to customize their portal. On June 18, 2012, Portlogic incorporated a wholly owned subsidiary, VOIP 1, Inc.

The Company hosts the portal software licensed to its customers on the Company�� own servers. The Company�� portal software products include an online administration interface which its customers can use to manage the functionality, appearance, and content of their portal, such as what users are able to see and do when they visit the portal. As a result, customers that license its software can operate their online portal using only a personal computer and Internet connection. They do not need to have any programming knowledge, additional software, hosting capabilities, or additional hardware.

The Company also offers, in exchange for additional licensing fees, plug-in products that can provide additional functions to the basic portal software licensed by the Company�� customers. The Company eithe! r owns the plug-ins or licenses them from third parties. The Company offers one fully developed portal software product. This product is an online social networking system marketed to entrepreneurs who wish to operate their own online social networking or dating business. The Company markets this product through one of its Websites, at www.internetdatingsoftware.com.

The m2Meet is a community networking software solution, being developed from its Web based source code. m2Bank is a financial transactions system that facilitates bill payments, money transfers, and account management. The m2Market is a mobile marketing solutions, including a Bluetooth push technology that is used to deliver marketing materials to mobile phones. The m2Ticket is a mobile ticketing sales engine, which manages the sale and delivery of tickets through mobile phones for the transportation and entertainment industry. The m2Kiosk is a line of standard and custom kiosks hardware and software which integrates with mobile phone applications in the marketing, financial, and ticketing industries. Its m2Workflow is a customer relations management (CRM) on mobile phones for service industries.

Advisors' Opinion:
  • [By Peter Graham]

    On Monday, small cap marijuana stocks Alternative Energy Partners Inc (OTCBB: AEGY) and Medical Cannabis Payment Solutions (OTCMKTS: REFG) surged 117.86% and 17.95%, respectively, while tech stock Portlogic Systems Inc (OTCMKTS: PGSY) sank 20%. However, it appears that only one of these small cap stocks has been the subject of disclosed paid promotions or investor relation activities. So what will these three small caps do today and the rest of the week? Here is a quick look to help you decide on a trading or investing strategy:

  • [By Peter Graham]

    Small cap stocks Muscle Warfare International (OTCMKTS: MWAR), Portlogic Systems Inc (OTCMKTS: PGSY) and Sterling Consolidated Corp (OTCBB: STCC) were all the subject of a few paid promotions as recently as last week but they sure did not start the new week out right because all were sinking on Monday. So are these small cap stocks that are either the subject of promotions or investor awareness campaigns hot or not? Here is a quick reality check:

Best High Tech Companies To Invest In Right Now: Affymax Inc.(AFFY)

Affymax, Inc., a biopharmaceutical company, engages in the development of drugs for the treatment of serious and life-threatening conditions. It develops peginesatide (Hematide), which has completed Phase III clinical trial for the treatment of anemia associated with chronic renal failure. Hematide is a synthetic peptide-based erythropoiesis stimulating agent designed to stimulate production of red blood cells. The company has strategic alliance agreements with Takeda Pharmaceutical Company Limited and Nektar Therapeutics AL, Corporation to develop and commercialize Hematide. Affymax, Inc. was founded in 2001 and is based in Palo Alto, California.

Advisors' Opinion:
  • [By Kanak Kanti De]

    Amgen needed an Onyx-like acquisition badly. For one, sales of Aranesp and Epogen, its flagship drugs for anemia, are dropping on concerns of safety, and loss of monopoly in 2012 to Affymax (AFFY), which received FDA approval for a rival anemia drug. (Note though, that after Omontys was recalled this year, that problem is resolved for Amgen.) Secondly, four of its top selling products go off patent in 2015.

  • [By Alpha Exposure]

    Investors in Affymax (AFFY) would like you to believe that Omontys will make a miraculous comeback and that Affymax will be a major winner. My belief is that the last AFFY article contained multiple factual errors that when refuted show that the future for Omontys is in fact dire. At the conclusion of this article all doubt should be removed regarding the low likelihood that Omontys returns to market.